Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover study of tiotropium + BI 54903 Respimat formulations in adults with asthma
2011-001801-29Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiotropium and ciclesonide in asthma (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: FEV1 AUC0-12h and systemic exposure. Started Oct 2011; status: terminated.
02
Drugs
tiotropiumciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2011-001801-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001801-29.